Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Brazil
/
Consumer Retailing
Create a narrative
Raia Drogasil Community
BOVESPA:RADL3 Community
3
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Raia Drogasil
Popular
Undervalued
Overvalued
Raia Drogasil
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Aging, Digitalization And Urbanization Will Drive Healthcare Growth
Key Takeaways Expanding digital and physical networks uniquely position Raia Drogasil to capture long-term market share, drive premium sales, and outperform consensus revenue and margin growth expectations. Aging demographics, proprietary offerings, and operational advances will accelerate recurring sales, boost efficiency, and deliver resilient, above-industry earnings regardless of economic headwinds.
View narrative
R$28.74
FV
38.1% undervalued
intrinsic discount
19.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Raia Drogasil
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Telemedicine Surge And Brazil Pricing Will Shrink Margins
Key Takeaways Virtual healthcare adoption and tighter drug pricing rules are constraining revenue growth and compressing margins across Raia Drogasil's retail operations. Competitive pressures and shifting consumer preferences are undermining store productivity, leading to weaker-than-expected earnings growth despite significant investments.
View narrative
R$14.50
FV
22.8% overvalued
intrinsic discount
12.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 2 months ago
author updated this narrative
Raia Drogasil
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Investments In Healthcare And AI Will Drive Future Operational Efficiencies And Profitability
Key Takeaways Focused investment in organic growth and digital channels aims to expand market share and boost long-term revenue through increased pharmacy footprint and online sales. Strategic healthcare and AI investments could lead to new revenue streams and efficiencies, while customer loyalty initiatives drive repeat sales and profitability.
View narrative
R$19.31
FV
7.8% undervalued
intrinsic discount
14.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
about 5 hours ago
author updated this narrative
Your Valuation for
RADL3
RADL3
Raia Drogasil
Your Fair Value
R$
Current Price
R$17.80
4.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
74b
2015
2018
2021
2024
2025
2027
2030
Revenue R$74.3b
Earnings R$2.2b
Advanced
Set Fair Value